Glycine vs Placebo for the Schizophrenia Prodrome

Clinical trial NCT00291226 · COMPLETED

Trial details

NCT number: NCT00291226
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Schizophrenia Prodrome

Start date: 2006-03-01
Primary completion: 2009-07-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.